Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.

[1]  D. de Zeeuw,et al.  High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case–control study with confirmation in diabetes , 2013, Journal of hypertension.

[2]  L. V. Van Pelt,et al.  High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. , 2012, European heart journal.

[3]  H. Brenner,et al.  Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. , 2012, Clinical chemistry.

[4]  Jin Zheng,et al.  Association between blood glucose levels and high-sensitivity cardiac troponin T in an overt cardiovascular disease-free community-based study. , 2012, Diabetes research and clinical practice.

[5]  Akshay S. Desai,et al.  Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  Akshay S. Desai,et al.  Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). , 2011, American heart journal.

[7]  N. Cook,et al.  Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus: The Women's Health Study , 2011, Circulation.

[8]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[9]  Michael J. Pencina,et al.  Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.

[10]  D. Atar,et al.  Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus , 2010, Cardiovascular diabetology.

[11]  A. Sjølie,et al.  Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes. , 2010, Journal of diabetes and its complications.

[12]  M. Pfeffer,et al.  A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[13]  Kdoqi.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  A. Khera,et al.  Prevalence and Determinants of Troponin T Elevation in the General Population , 2006, Circulation.

[15]  T. Forst,et al.  High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. , 2006, Diabetes technology & therapeutics.

[16]  H. Parving,et al.  Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy , 2004, Diabetologia.

[17]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[18]  K Borch-Johnsen,et al.  Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study , 1996, BMJ.

[19]  J. Bröchner-Mortensen,et al.  Selection of routine method for determination of glomerular filtration rate in adult patients. , 1976, Scandinavian journal of clinical and laboratory investigation.